MedImmune

NCT03555994

Phase 2Completed201851 people14 Jun 2018clinicaltrials.gov

NCT03444584

Phase 2Completed201849 people23 Feb 2018clinicaltrials.gov

NCT03347968

Phase 1Completed201722 people20 Nov 2017clinicaltrials.gov

NCT03235050

CollaboratorPhase 2Completed2017834 people1 Aug 2017clinicaltrials.gov

NCT01861340

CollaboratorEarly phase 1Completed201420 people23 May 2013clinicaltrials.gov

NCT01498952

Phase 1Completed20126 people26 Dec 2011clinicaltrials.gov

NCT00072930

Phase 2Completed2003150 people17 Nov 2003clinicaltrials.gov